Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New shot aims to stop cancer patients from wasting away during chemo

NCT ID NCT06937177

First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 30 times

Summary

This study tests a daily injection called TCMCB07 in 120 people with newly diagnosed colorectal cancer who are starting chemotherapy. The goal is to see if the drug can help patients maintain body weight and muscle mass, and reduce side effects like loss of appetite. Participants will receive either the drug or a placebo for 12 weeks, starting from their second chemo cycle.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER WEIGHT LOSS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Investigative Site

    RECRUITING

    Tucson, Arizona, 85715, United States

  • Investigative Site

    RECRUITING

    Los Angeles, California, 90048, United States

  • Investigative Site

    RECRUITING

    Los Angeles, California, 90095, United States

  • Investigative Site

    RECRUITING

    Hialeah, Florida, 33013, United States

  • Investigative Site

    RECRUITING

    Margate, Florida, 33063, United States

  • Investigative Site

    RECRUITING

    Miami Beach, Florida, 33140, United States

  • Investigative Site

    RECRUITING

    Tamarac, Florida, 33321, United States

  • Investigative Site

    RECRUITING

    Atlanta, Georgia, 30318, United States

  • Investigative Site

    NOT_YET_RECRUITING

    Chicago, Illinois, 60611, United States

  • Investigative Site

    NOT_YET_RECRUITING

    Hinsdale, Illinois, 60521, United States

  • Investigative Site

    NOT_YET_RECRUITING

    Skokie, Illinois, 60077, United States

  • Investigative Site

    RECRUITING

    Wichita, Kansas, 67214, United States

  • Investigative Site

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Investigative Site

    RECRUITING

    Lincoln, Nebraska, 68506, United States

  • Investigative Site

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • Investigative Site

    RECRUITING

    New York, New York, 10016, United States

  • Investigative Site

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Investigative Site

    RECRUITING

    Oklahoma City, Oklahoma, 73102, United States

  • Investigative Site

    NOT_YET_RECRUITING

    Charleston, South Carolina, 29425, United States

  • Investigative Site

    RECRUITING

    Memphis, Tennessee, 38120, United States

  • Investigative Site

    RECRUITING

    Kingwood, Texas, 77090, United States

  • Investigative Site

    RECRUITING

    Laredo, Texas, 78041, United States

  • Investigative Site

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • Investigative Site

    RECRUITING

    Edmonton, Alberta, T6G 1Z2, Canada

  • Investigative site

    RECRUITING

    Coral Springs, Florida, 33071, United States

  • Investigative site

    NOT_YET_RECRUITING

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.